1-11 of 11
Yutaka Niihara
Close
Sort by
Journal Articles

Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance

Bhawna Rastogi, Sunita Rani, Meiko Mayuzumi, Rafael Razon, Rajani Singh, Jason Goodrow, Joseph M Becerra, Charles W Stark, Yutaka Niihara
Journal: Blood
Blood (2021) 138 (Supplement 1): 4184.
https://doi.org/10.1182/blood-2021-154051
Published: 2021
Journal Articles

The Evaluation of Transfusion Data from the Phase 3 Clinical Study of L-Glutamine in Sickle Cell Disease

Hung Lam, Joseph M Becerra, Charles W Stark, Yutaka Niihara, Michael Callaghan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3116.
https://doi.org/10.1182/blood-2021-154477
Published: 2021
Journal Articles

New Anti-Cancer Drug Compounds to Treat FLT-3 Mutated Leukemia

Joan Oliva, Larakaye Villanueva, Jun Ochiai, Yutaka Niihara
Journal: Blood
Blood (2021) 138 (Supplement 1): 4349.
https://doi.org/10.1182/blood-2021-153894
Published: 2021
Journal Articles

New Anti-Cancer Drug Compounds to Treat Mutated Waldenstrom Myd88 L265P

Joan Oliva, Larakaye Villanueva, Jun Ochiai, Yutaka Niihara
Journal: Blood
Blood (2021) 138 (Supplement 1): 4370.
https://doi.org/10.1182/blood-2021-153712
Published: 2021
Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1065.
https://doi.org/10.1182/blood-2018-99-119720
Published: 2018
Journal Articles

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Yutaka Niihara, MD, Rafael Razon, MD, Suvankar Majumdar, MD, Brian Claggett, PhD, Onyinye C. Onyekwere, MD, Alan Ikeda, MD, Tammuella Singleton, MD, Andrew Kohei Wood, MS, Rajani Singh, BS, Lan Tran, MPH, Charles William Stark, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 685.
https://doi.org/10.1182/blood.V130.Suppl_1.685.685
Published: 2017
Journal Articles

Phase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle β 0 -Thalassemia Subgroup Analyses Show Consistent Clinical Improvement

Yutaka Niihara, MD, Kusum Viswanathan, MD, Scott T. Miller, MD, Edouard Guillaume, MD, Miren Blackwood, Rafael Razon, MD, Lan Tran, MPH, Charles Stark, Pharm D
Journal: Blood
Blood (2016) 128 (22): 1318.
https://doi.org/10.1182/blood.V128.22.1318.1318
Published: 2016
Journal Articles

Decrease in the Severity of Painful Sickle Cell Crises with Oral Pglg

Yutaka Niihara, MD, Lan Tran, MPH, Rafael Razon, MD, Charles Stark, Pharm D, Henry Macan, MD
Journal: Blood
Blood (2015) 126 (23): 2175.
https://doi.org/10.1182/blood.V126.23.2175.2175
Published: 2015
Journal Articles

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Yutaka Niihara, MD, Han A. Koh, MD, Lan Tran, MPH, Rafael Razon, MD, Henry Macan, MD, Charles Stark, Pharm.D, Ted Wun, MD, Patricia Adams-Graves, MD
Journal: Blood
Blood (2014) 124 (21): 86.
https://doi.org/10.1182/blood.V124.21.86.86
Published: 2014
Journal Articles

L-Glutamine Therapy Improves Minute Ventilation of Sickle Cell Anemia Patients.

Henry R. Macan, MD, Janos Porszasz, MD, PhD, Hideki Tsurugaya, MD, PhD, Rafael L. Razon, MD, Han Koh, MD, Richard Casaburi, PhD, MD, Kouichi R. Tanaka, MD, Yutaka Niihara, MD, MPH
Journal: Blood
Blood (2007) 110 (11): 3783.
https://doi.org/10.1182/blood.V110.11.3783.3783
Published: 2007
Journal Articles

L-Glutamine Therapy Increases Exercise Endurance of Sickle Cell Anemia Patients.

Henry R. Macan, M.D., Richard Casaburi, Ph.D., M.D., Hideki Tsurugaya, M.D., Janos Porszasz, M.D., M.D., Han Koh, M.D., Kouichi R. Tanaka, M.D., Yutaka Niihara, M.D.
Journal: Blood
Blood (2004) 104 (11): 3729.
https://doi.org/10.1182/blood.V104.11.3729.3729
Published: 2004